| 861/1507 | US=64 / Câncer Kaufman JL, Mihelic R, Lonial S. Maintenance therapy in multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 91-8. (Comtemporary Hematology) ISBN 978-1-934115-82-4. |
| 862/1507 | US=64 / Câncer Sara B, Antonio P. Therapy for patients not eligible for autologous transplant. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 99-112. (Comtemporary Hematology) ISBN 978-1-934115-82-4. TERAPIA PARA PACIENTES NAO COMPATIVEL TRANSPLANTE; TRANSPLANTE AUTOLOGO; QUIMIOTERAPIA CONVENCIONAL |
| 863/1507 | US=64 / Câncer Ailawadhi S, Chanan-Khan A. Current role of anthracyclines in the treatment of multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 113-21. (Comtemporary Hematology) ISBN 978-1-934115-82-4. TRATAMENTO DO MIELOMA MULTIPLO. ANTRACICLINAS; ANTRACICLINAS |
| 864/1507 | US=64 / Câncer Wang F, Waller EK. Allogeneic transplantation for multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 125-42. (Comtemporary Hematology) ISBN 978-1-934115-82-4. TRANSPLANTE ALOGENICO DE MIELOMA MULTIPLO; CLONAL DE CELULAS B; IMUNOTERAPIA ANTI MIELOMA |
| 865/1507 | US=64 / Câncer Munshi NC, Tai YT. Antibody and other immune-based therapies for myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 167-202. (Comtemporary Hematology) ISBN 978-1-934115-82-4. ANTICORPOS; IMUNO-TERAPIAS BASEADAS PARA MIELOMA; ANTICORPOS CONTRA O TUMOR |
| 866/1507 | US=64 / Câncer Badros A. Thalidomide in patients with relapsed multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 205-27. (Comtemporary Hematology) ISBN 978-1-934115-82-4. TALIDOMIDA EM PACIENTES MIELOMA MULTIPLO; TALIDOMIDA E MIELOMA |
| 867/1507 | US=64 / Câncer Buadi FK, Rajkumar SV. Thalidomide: induction therapy. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 229-37. (Comtemporary Hematology) ISBN 978-1-934115-82-4. TALIDOMIDA; TERAPIA DE INDUCAO; MIELOMA MULTIPLO; CLONAL DE CELULAS ESTAMINAIS |
| 868/1507 | US=64 / Câncer Richardson PG, Mitsiades CS, Schlossman R, Hideshima T, Ghobrial I, Munshi NC, Anderson KC. The role of bortezomib in the treatment of relapsed and refractory multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 239-52. (Comtemporary Hematology) ISBN 978-1-934115-82-4. |
| 869/1507 | US=64 / Câncer San MFJ, Mateos MV. Bortezomib as induction therapy in patients with multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 253-63. (Comtemporary Hematology) ISBN 978-1-934115-82-4. BORTEZOMIB; PACIENTES COM MIELOMA MULTIPLO. TERAPIA DE INDUCAO |
| 870/1507 | US=64 / Câncer Yhomas SK, Richards TA, Weber DM. Lenalidomide in relapsed or refractory multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 265-77. (Comtemporary Hematology) ISBN 978-1-934115-82-4. LENALIDOMIDA EM RECIDIVA; MIELOMA MULTIPLO REFRACTARIO; ESTEROIDES; ANTRACICLINAS |
| 871/1507 | US=64 / Câncer Kumar S. Lenalidomide for initial therapy of newly diagnosed multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 279-88. (Comtemporary Hematology) ISBN 978-1-934115-82-4. LENALIDOMIDA. TERAPIA COM MIELOMA MULTIPLO; MALIGNIDADE HEMATOLOGICA. LINFOMA NAO-HODGKIN |
| 872/1507 | US=64 / Câncer Mitsiades CS, Hideshima T, Munshi NC, Richardson PG, Anderson KC. The role of heat shock protein 90 as a therapeutic target for multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 291-308. (Comtemporary Hematology) ISBN 978-1-934115-82-4. TERAPEUTICO PARA O MIELOMA MULTIPLO; CHAPERONE MOLECULAR UBIQUAMENTE |
| 873/1507 | US=64 / Câncer Harvey RD, Silberman J, Lonmial S. The PI3 kinase/akt pathway as a therapeutic target in multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 309-22. (Comtemporary Hematology) ISBN 978-1-934115-82-4. PI3 QUINASE; AKT; TERAPEUTICO NO MIELOMA MULTIPLO; MIELOMA MULTIPLO. TERAPIAS |
| 874/1507 | US=64 / Câncer Frost P, Lichtenstein A. The mammalian target of rapamycin and multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 323-30. (Comtemporary Hematology) ISBN 978-1-934115-82-4. RAPAMICINA EM MAMIFEROS; MIELOMA MULTIPLO; CELULAS EUCARIOTICAS; IMUNO-HISTOQUIMICA |
| 875/1507 | US=64 / Câncer Dai Y, Grant S. CDK inhibitors in multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 331-63. (Comtemporary Hematology) ISBN 978-1-934115-82-4. INIBIDORES DE CDK NO MIELOMA MULTIPLO; PROGRESSAO DO CICLO CELULAR; QUINASES DEPENDENTES DE CICLINA |
| 876/1507 | US=64 / Câncer Jiménez-Zepeda VH, Stewart AK. Fibroblast growth, factor receptor 3 and multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 365-78. (Comtemporary Hematology) ISBN 978-1-934115-82-4. CRESCIMENTO DE FIBROBLASTOS; RECEPTOR DO FACTOR DE 3; MIELOMA MULTIPLO; TRANSLOCACOES CROMOSSOMICAS |
| 877/1507 | US=64 / Câncer Hideshima T. Histone deacetylase inhibitors in multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 379-92. (Comtemporary Hematology) ISBN 978-1-934115-82-4. |
| 878/1507 | US=64 / Câncer Mollinedo F. Death receptors in multiple myeloma and therapeutic opportunities. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 393-419. (Comtemporary Hematology) ISBN 978-1-934115-82-4. |
| 879/1507 | US=64 / Câncer Chauhan D, Singh A, Anderson K. Proteasome inhibitors as therapy in multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 421-32. (Comtemporary Hematology) ISBN 978-1-934115-82-4. TERAPIA EM MIELOMA MULTIPLO. INIBIDORES DE PROTEASSOMA; HOMEOSTASE CELULAR NORMAL; AGENTES ANTICANCERIGENOS. INIBIDORES DE PROTEASSOMA |
| 880/1507 | US=64 / Câncer Mark TM, Pearse RN. Pathophysiology of bone disease in multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 435-54. (Comtemporary Hematology) ISBN 978-1-934115-82-4. DOENCA OSSEA DO MIELOMA MULTIPLO. FISIOPATOLOGIA; MIELOMA MULTIPLO; MALIGNIDADE DE CELULAS PLASMATICAS; CRESCIMENTO DA MEDULA OSSEA |